MINNEAPOLIS, June 6, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that its President and CEO David Kaysen will ring the NASDAQ Stock Market Closing Bell on Tuesday, June 7, 2011. The ceremony, held at the NASDAQ MarketSite at Times Square in New York City, will be broadcast live beginning at 3:45 p.m. ET via the NASDAQ webcam. The live ceremony, including Mr. Kaysen's remarks, can be viewed online at http://www.nasdaq.com/about/marketsitetowervideo.asx. Archived event photos and video will also be available online, at http://www.nasdaq.com/marketsite/marketsite_events.stm.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.
For Further Information:
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, Treasurer
Doug Sherk/Jenifer Kirtland (Investors), 415.896.6820
Chris Gale (Media), 646.201.5431
SOURCE Uroplasty, Inc.